<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:58:25Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4589073" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4589073</identifier><datestamp>2015-10-01</datestamp><setSpec>bmcmd</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
      <journal-title-group>
        <journal-title>BMC Medical Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2350</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4589073</article-id>
      <article-id pub-id-type="pmcid">PMC4589073</article-id>
      <article-id pub-id-type="pmc-uid">4589073</article-id>
      <article-id pub-id-type="pmid">26420286</article-id>
      <article-id pub-id-type="publisher-id">231</article-id>
      <article-id pub-id-type="doi">10.1186/s12881-015-0231-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>NPHS2</italic> mutations account for only 15Â % of nephrotic syndrome cases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Guaragna</surname>
            <given-names>Mara Sanches</given-names>
          </name>
          <address>
            <phone>+ 55 19 3521 1091</phone>
            <email>mara.guaragna@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lutaif</surname>
            <given-names>Anna Cristina GB</given-names>
          </name>
          <address>
            <email>aclutaif@uol.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piveta</surname>
            <given-names>Cristiane SC</given-names>
          </name>
          <address>
            <email>cristianepiveta@yahoo.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Marcela L.</given-names>
          </name>
          <address>
            <email>malopes.souza@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Souza</surname>
            <given-names>SuÃ©llen R.</given-names>
          </name>
          <address>
            <email>suellen.souza05@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Henriques</surname>
            <given-names>Taciane B.</given-names>
          </name>
          <address>
            <email>tacianebh@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maciel-Guerra</surname>
            <given-names>AndrÃ©a T.</given-names>
          </name>
          <address>
            <email>atmg@uol.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Belangero</surname>
            <given-names>Vera MS</given-names>
          </name>
          <address>
            <email>vmsbelangero@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Guerra-Junior</surname>
            <given-names>Gil</given-names>
          </name>
          <address>
            <email>gileandrea@uol.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
          <xref ref-type="aff" rid="Aff5"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>De Mello</surname>
            <given-names>Maricilda P.</given-names>
          </name>
          <address>
            <email>mpmello869@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Centro de Biologia Molecular e Engenharia GenÃ©tica, Universidade Estadual de Campinas, Campinas, SÃ£o Paulo, Caixa Postal 6010 Brasil </aff>
        <aff id="Aff2"><label/>Nefrologia PediÃ¡trica, Departamento de Pediatria, Faculdade de CiÃªncias MÃ©dicas, Universidade Estadual de Campinas, Campinas, SÃ£o Paulo, Brasil </aff>
        <aff id="Aff3"><label/>Centro de InvestigaÃ§Ã£o em Pediatria, Faculdade de CiÃªncias MÃ©dicas, Universidade Estadual de Campinas, Campinas, SÃ£o Paulo, Brasil </aff>
        <aff id="Aff4"><label/>Departamento de GenÃ©tica MÃ©dica, Faculdade de CiÃªncias MÃ©dicas, Universidade Estadual de Campinas, Campinas, SÃ£o Paulo, Brasil </aff>
        <aff id="Aff5"><label/>Grupo Interdisciplinar de Estudos da DeterminaÃ§Ã£o e DiferenciaÃ§Ã£o do Sexo, Faculdade de CiÃªncias MÃ©dicas, Universidade Estadual de Campinas, Campinas, SÃ£o Paulo, Brasil </aff>
        <aff id="Aff6"><label/>Endocrinologia PediÃ¡trica, Departamento de Pediatria, Faculdade de CiÃªncias MÃ©dicas, Universidade Estadual de Campinas, Campinas, SÃ£o Paulo, Brasil </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>29</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>88</elocation-id>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>9</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© Guaragna et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Nephrotic syndrome is traditionally classified on the basis of the response to standard steroid treatment. Mutations in more than 24 genes have been associated with nephrotic syndrome in children, although the great majority of steroid-resistant cases have been attributed to mutations in three main genes: <italic>NPHS1</italic>, <italic>NPHS2</italic> and <italic>WT1</italic>. The aims of this study were to identify mutations in these genes more frequently reported as mutated and to characterize each variation using different <italic>in silico</italic> prediction algorithms in order to understand their biological functions.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>We performed direct sequence analysis of exons 8 and 9 of <italic>WT1</italic>, 8 exons of <italic>NPHS2</italic> and 29 exons of <italic>NPHS1</italic>, including <italic>NPHS2</italic> and <italic>NPHS1</italic> intronâexon boundary sequences, as well as 700Â bp of the 5â² UTR from both genes in 27 steroid-resistant patients aged between 3Â months and 18Â years.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Analysis of the <italic>NPHS2</italic> gene revealed four missense mutations, one frameshift mutation and three variations in the 5â² UTR. Four patients presented compound heterozygosis, and four other patients presented one heterozygous alteration only. <italic>WT1</italic> and <italic>NPHS1</italic> gene analysis did not reveal any mutations.</p>
        </sec>
        <sec>
          <title>Discussion</title>
          <p> This is the first study focusing on genetics ofÂ SRNS in Brazilian children. Identification of mutations is important because it couldÂ influence physiciansâ decision on patient treatment, as patients carrying mutations canÂ be spared the side effects of immunosuppressive therapy and ultimately could beÂ considered for kidney transplantation from a living donor.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>After molecular analysis of the genes more frequently reported as mutated in 27 steroid-resistant nephrotic syndrome patients, we identified <italic>NPHS2</italic> mutations confirming the hereditary character of the kidney disease in only 14.8Â % of patients. Therefore, the next step is to perform a next generation sequencing based analysis of glomeluropathy-related panel of genes for the remaining patients in order to search for mutations in other genes related to steroid-resistant nephrotic syndrome.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12881-015-0231-9) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Steroid-resistant nephrotic syndrome</kwd>
        <kwd>Children</kwd>
        <kwd>Adolescents</kwd>
        <kwd>Mutations</kwd>
        <kwd>
          <italic>NPHS2</italic>
        </kwd>
        <kwd>
          <italic>NPHS1</italic>
        </kwd>
        <kwd>
          <italic>WT1</italic>
        </kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>Â© The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Nephrotic syndrome (NS) is considered as one of the main kidney diseases in children and is characterized by proteinuria, edema, hypoalbuminemia and hyperlipidemia [<xref ref-type="bibr" rid="CR1">1</xref>]. Depending on the age at diagnosis, NS is usually classified as congenital (CNS) when it manifests <italic>in utero</italic> or during the first 3Â months of life; as infantile when it occurs during the first year; as childhood when symptoms occur between 1 and 12Â years of age; and as juvenile with onset between 12 and 18Â years of age [<xref ref-type="bibr" rid="CR2">2</xref>]. Approximately 90Â % of patients show a favorable outcome after steroid treatment of NS and are termed steroid-sensitive NS (SSNS) patients. Clinically, however, these SSNS patients are not a homogeneous group, as some continue to develop frequent relapses (FRNS) or even follow a steroid-dependent course (SDNS) of the disease. The remaining 10Â % are steroid-resistant NS (SRNS) patients who do not respond to steroids or to any other immunosuppressive therapy; they show most commonly histopathological findings of focal segmental glomerulosclerosis (FSGS) and generally progress to end-stage renal disease [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
      <p>A single-gene cause is responsible for approximately 30Â % of SRNS cases, as reported in a recent paper by Sadowski et al. [<xref ref-type="bibr" rid="CR3">3</xref>] on the largest international cohort studied so far for monogenic causes of SRNS. By using an in-house developed high-throughput approach, the investigators examined 1783 families and identified mutations in 21 out of 27 genes encoding proteins mainly expressed in the glomerular filtration barrier (GFB). The clinical course in affected children differs considerably with respect to the mode of inheritance, age, renal biopsy results, response to immunosuppressive treatment and extrarenal manifestations. One of the main genes, <italic>NPHS2</italic> (OMIM *604766), encodes podocin, a member of the stomatin protein family that is localized at the slit membrane [<xref ref-type="bibr" rid="CR4">4</xref>]. In the slitâdiaphragm (SD) complex, podocin interacts with nephrin, a member of the immunoglobulin superfamily and the principal protein in the SD [<xref ref-type="bibr" rid="CR5">5</xref>]. Podocin mediates the recruitment of nephrin into specialized microdomains of the cell plasma membrane where, in the so-called âlipid raftsâ, both proteins play essential roles in the maintenance of the glomerular permeability barrier [<xref ref-type="bibr" rid="CR6">6</xref>]. Moreover, podocin belongs to a family comprising more than 1800 proteins conserved throughout evolution that share approximately 150 amino acid domains similar to mitochondrial protein prohibitin (PHB). Many of the PHB domain proteins regulate membrane protein function by binding sterols and altering their local lipid environment [<xref ref-type="bibr" rid="CR7">7</xref>]. Huber et al. [<xref ref-type="bibr" rid="CR8">8</xref>] demonstrated that podocin binds to cholesterol and contributes to form a supercomplex of proteins and lipids that regulate ion channel complexes; the authors also showed that podocin interacts with the cytoplasmic tail of nephrin, thus potentiating the effect of nephrin cellular signaling.</p>
      <p>Mutations in the <italic>NPHS2</italic> gene were originally described in families with autosomal recessive SRNS (nephrotic syndrome type 2, OMIM #600995) [<xref ref-type="bibr" rid="CR8">8</xref>] but later were found to be present also in sporadic cases [<xref ref-type="bibr" rid="CR9">9</xref>], occurring in approximately 40Â % of familial cases and 6â17Â % of sporadic SRNS cases [<xref ref-type="bibr" rid="CR9">9</xref>â<xref ref-type="bibr" rid="CR11">11</xref>]. Familial and sporadic cases with compound heterozygous or homozygous mutations in <italic>NPHS2</italic> typically have disease onset between 3Â months and 5Â years of age. Recently, Bouchireb et al. [<xref ref-type="bibr" rid="CR12">12</xref>] pointed out that not all ethnic groups share the same frequency of mutations in this gene, following an extensive review of <italic>NPHS2</italic> mutations in SRNS patients between 1999 and 2013. It was found that African-American and Asian patients show a low prevalence of <italic>NPHS2</italic> mutations.</p>
      <p>Regarding the <italic>NPHS1</italic> gene (OMIM *602716) that encodes nephrin, two major mutations were originally identified in Finnish patients with CNS of the Finnish type (OMIM #256300) [<xref ref-type="bibr" rid="CR13">13</xref>]. In non-Finnish patients, a large number of different mutations have been described [<xref ref-type="bibr" rid="CR13">13</xref>â<xref ref-type="bibr" rid="CR15">15</xref>]. In addition to the typical features of CNS, mutations in nephrin were also associated with childhood-onset SRNS in patients aged from 5Â months to 8Â years [<xref ref-type="bibr" rid="CR16">16</xref>]. Furthermore, Koziell et al. [<xref ref-type="bibr" rid="CR17">17</xref>] described the coexistence of mutations in <italic>NPHS2</italic> and <italic>NPHS1</italic> genes in patients with milder CNS.</p>
      <p>A third important gene involved in the genetics of NS is <italic>WT1</italic> (OMIM *607102), which encodes a zinc finger transcription factor. <italic>WT1</italic>-dominant mutations were originally identified to be responsible for Wilmsâ tumor (WT), a childhood kidney cancer (OMIM #194070) [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. <italic>WT1</italic> mutations were also associated with Denys-Drash syndrome (OMIM #194080) [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>] and Frasier syndrome (OMIM #136680) [<xref ref-type="bibr" rid="CR22">22</xref>]. However, dominant <italic>de novo</italic> mutations in exons 8 and 9 have been found as the cause of approximately 2.7â7Â % of sporadic cases of isolated SRNS in infants and children. In a recent study, Lipska et al. [<xref ref-type="bibr" rid="CR23">23</xref>] used the PodoNet cohort to describe the genotypic and phenotypic spectrum of <italic>WT1</italic>-associated kidney disease and found <italic>WT1</italic> mutations in 6Â % of sporadic SRNS patients, confirming the prevalence found by previous smaller studies.</p>
      <p>Molecular data are clinically relevant to SRNS patients, because children who do not respond to corticosteroids and present with mutations in any of these genes can be spared the adverse effects of corticosteroid treatment. In addition, patients with mutations have a reduced risk of developing FSGS after renal transplantation, compared to patients without mutations, at a rate of 8Â % versus 30Â %, respectively [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
      <p>In our study, we performed sequence analysis of the entire <italic>NPHS2</italic> and <italic>NPHS1</italic> genes and exons 8 and 9 of the <italic>WT1</italic> gene in 27 SRNS Brazilian patients, including seven unrelated familial cases and 20 sporadic cases. We present nucleotide changes found after screening these 27 SRNS patients.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Patients</title>
        <p>Between 2008 and 2013, 27 SRNS patients, comprising seven unrelated familial cases and 20 sporadic (isolated) cases, were included in this study. Prerequisites for enrollment included the presence of NS for at least 1Â year and the age at disease onset being between 3Â months and 18Â years of age. The median age at disease onset was 4Â years. From the 27 patients, 15 were males and 12 were females. Resistance to steroids was defined by nephrologists who followed up the patients, according to the International Study of Kidney Disease in Children definition [<xref ref-type="bibr" rid="CR24">24</xref>]. The definition of chronic kidney disease (CKD) was classified according to the National Kidney Foundation for patients aged over 2Â years [<xref ref-type="bibr" rid="CR25">25</xref>]. Eight of 27 patients progressed to CKD and had already had a kidney transplant. TableÂ <xref rid="Tab1" ref-type="table">1</xref> presents the age at disease onset, age at CKD diagnosis and at transplantation, and biopsy and molecular findings. The Ethics Committee from Faculdade de CiÃªncias MÃ©dicas at Universidade Estadual de Campinas approved this study. Written informed consent for the study was obtained from all patients and their parents.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical data of SRNS patients with <italic>NPHS2</italic> and <italic>NPHS1</italic> alterations</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Patient number</th><th rowspan="3">Gender</th><th rowspan="3">Sporadic/ familial<sup>a</sup>
</th><th rowspan="3">Age at onset (years)</th><th rowspan="3">Renal Biopsy<sup>b</sup>
</th><th rowspan="2">Age of onset to CKD - V (Yes/No)<sup>c</sup>
</th><th rowspan="2">Age of transplant (Yes/No)</th><th colspan="3">
<italic>NPHS2</italic>
</th></tr><tr><th rowspan="2">Nucleotide change</th><th rowspan="2">Effect on coding</th><th rowspan="2">Ref.</th></tr><tr><th>(years)</th><th>(years)</th></tr></thead><tbody><tr><td colspan="10">Steroid Resistant cases with two NPHS2 heterozygous alterations</td></tr><tr><td rowspan="2">P6</td><td rowspan="2">F</td><td rowspan="2">spo</td><td rowspan="2">12</td><td rowspan="2">FSGS</td><td rowspan="2">Yes/15</td><td rowspan="2">Yes/15</td><td>c.686Gâ&gt;âA</td><td>p.Arg229Gln</td><td>[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>c.851Câ&gt;âT</td><td>p.Ala284Val</td><td>[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td rowspan="2">P67</td><td rowspan="2">F</td><td rowspan="2">spo</td><td rowspan="2">2.2</td><td rowspan="2">DMP</td><td rowspan="2">No</td><td rowspan="2">No</td><td>c.686Gâ&gt;âA</td><td>p.Arg229Gln</td><td>[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>c.928Gâ&gt;âA</td><td>p.Glu310Lys</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td rowspan="2">P103</td><td rowspan="2">F</td><td rowspan="2">fam</td><td rowspan="2">1.2</td><td rowspan="2">FSGS</td><td rowspan="2">No</td><td rowspan="2">No</td><td>c.714delG</td><td>p.Lis239Argfs*13</td><td>ps</td></tr><tr><td>c.779Â Tâ&gt;âA</td><td>p.Val260Glu</td><td>[<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td rowspan="2">P154</td><td rowspan="2">M</td><td rowspan="2">fam</td><td rowspan="2">13</td><td rowspan="2">FSGS</td><td rowspan="2">No</td><td rowspan="2">No</td><td>c.686Gâ&gt;âA</td><td>p.Arg229Gln</td><td>[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>c.851Câ&gt;âT</td><td>p.Ala284Val</td><td>[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td colspan="10">Steroid Resistant cases with one NPHS2 heterozygous alteration</td></tr><tr><td>P111</td><td>F</td><td>spo</td><td>3</td><td>FSGS</td><td>No</td><td>No</td><td>c.-164Câ&gt;âT</td><td>-</td><td>ps</td></tr><tr><td>P68</td><td>M</td><td>spo</td><td>4</td><td>CO</td><td>No</td><td>No</td><td>c.-196Câ&gt;âG</td><td>-</td><td>ps</td></tr><tr><td>P85</td><td>M</td><td>spo</td><td>6.11</td><td>CO</td><td>Yes/8</td><td>Yes</td><td>c.-537_-531delCTTTTTT</td><td>-</td><td>[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td>P72</td><td>M</td><td>fam</td><td>16</td><td>FSGS</td><td>Yes/18</td><td>Yes/18</td><td>c.686Gâ&gt;âA</td><td>p.Arg229Gln</td><td>[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>
<italic>Spo</italic>: sporadic; <italic>Fam</italic>: familial;<sup>b</sup>
<italic>FSGS</italic>:focal segmental glomerular sclerosis; <italic>DMP</italic>: diffuse mesangial proliferation; <italic>CO</italic>: complexâ=âminimal change disease or diffuse mesangial proliferation or focal segmental glomerular sclerosis; <italic>CKD</italic>: <sup>c</sup>chronic kidney disease; <italic>n.a</italic>.: not analyzed; <italic>nd</italic>: not determined</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec4">
        <title>Molecular analysis of <italic>NPHS2</italic>, <italic>NPHS1</italic> and <italic>WT1</italic> genes</title>
        <p>Genomic DNA was isolated from blood samples using standard methods [<xref ref-type="bibr" rid="CR26">26</xref>]. Amplification of all coding exons, exonâintron boundaries and 700Â bp of the 5â² UTR end from both <italic>NPHS2</italic> and <italic>NPHS1</italic> genes were performed by polymerase chain reaction (PCR). For <italic>WT1</italic> gene we performed amplification of exons 8 and 9 only (for specific primers, see in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Tables S1, S2 and S3). After PCR reactions and direct sequencing of products (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>), Chromas Pro v.1.5 and CLC Sequence Viewer v.6.6.2, were used to analyze and compare these sequences with the <italic>NPHS2</italic>, <italic>NPHS1</italic> and <italic>WT1</italic> reference sequences in the Ensembl database (ENSG00000116218, ENSG00000161270, ENSG00000184937, respectively; <ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/index.html">http://www.ensembl.org/index.html</ext-link>).</p>
      </sec>
      <sec id="Sec5">
        <title>Bioinformatics analysis</title>
        <p>The impact of missense and 5â² UTR variations on podocin or nephrin structure and function was evaluated using selected bioinformatics tools. SIFT (<bold><italic>S</italic></bold><italic>orting</italic><bold><italic>I</italic></bold><italic>ntolerant</italic><bold><italic>F</italic></bold><italic>rom</italic><bold><italic>T</italic></bold><italic>olerant</italic>;<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/"> http://sift.jcvi.org/</ext-link>) [<xref ref-type="bibr" rid="CR27">27</xref>], Polyphen (<bold><italic>Poly</italic></bold><italic>morphism</italic><bold><italic>Phen</italic></bold><italic>otyping</italic>; <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>) [<xref ref-type="bibr" rid="CR28">28</xref>] and Align GVGD (<ext-link ext-link-type="uri" xlink:href="http://agvgd.iarc.fr/agvgd_input.php">http://agvgd.iarc.fr/agvgd_input.php/</ext-link>) [<xref ref-type="bibr" rid="CR29">29</xref>] were used to assess potentially damaging effects of non-synonymous amino acid substitutions (see in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S4). In order to verify conserved amino acid residues, we performed multiple alignment analysis using ClustalW program [<xref ref-type="bibr" rid="CR30">30</xref>] that lines up orthologs from different species to reveal the identities, similarities and differences. Human nephrin and podocin sequences were compared with orthologous sequences available in UniProt data bank (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/">http://www.uniprot.org/</ext-link>). Moreover, in order to better understand if missense mutations affected exonic splicing enhancers or silencers (ESEs and ESS, respectively) leading to splicing defects, we further performed prediction analysis using two premRNA splicing prediction tools: Human Splicing Finder (HSF) [<xref ref-type="bibr" rid="CR31">31</xref>] and SpliceAid2 [<xref ref-type="bibr" rid="CR32">32</xref>]. The three 5â² UTR heterozygous alterations were analyzed using Alibaba2 gene regulation program (<ext-link ext-link-type="uri" xlink:href="http://www.gene-regulation.com/pub/programs/alibaba2/index.html">http://www.gene-regulation.com/pub/programs/alibaba2/index.html</ext-link>) that predicts transcription factor binding sites in the DNA query using data from TRANSFACÂ® Public eukaryotic transcription factors [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec6" sec-type="results">
      <title>Results and discussion</title>
      <p>Since the discovery that inherited structural defects in the GFB are responsible for a large proportion of SRNS cases, major breakthrough studies on the discovery of genes and their implication in the disease have been carried out mainly in European and North American countries [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. In Brazil, genetic screening of patients with NS in childhood is still incipient. This is the first study focusing on genetics of SRNS in Brazilian children. Identification of mutations is important because it could influence physiciansâ decision on patient treatment, as patients carrying mutations can be spared the side effects of immunosuppressive therapy and ultimately could be considered for kidney transplantation from a living donor.</p>
      <p>Here we present results for a cohort of 27 SRNS patients from a public hospital that is a reference center in the South East region of Brazil where approximately 200 patients with NS are routinely followed up. Of note, the 27 SRNS patients represented a frequency of 13.5Â % (27/200), which is in line with the reported worldwide frequency of 10â20Â % for this form of the disease [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. However, the cohort was not representative of the entire country, since the Brazilian population consists of about 205 million of highly miscegenated people with diverse and regional features. However, there is no other genetic study on NS patients in Brazil for comparison.</p>
      <p>Only four patients (two familial and two sporadic cases) representing a total of 14.8Â % showed two heterozygous alterations that confirmed the hereditary character of their kidney disease. Mutations in <italic>WT1</italic> exons 8 and 9 and <italic>NPHS1</italic> gene were not found. <italic>NPHS2</italic> analysis, however, showed eight alterations: four missense mutations, one frameshift mutation and three variations in the 5â UTR (TableÂ <xref rid="Tab1" ref-type="table">1</xref>).</p>
      <sec id="Sec7">
        <title>Sporadic cases</title>
        <p>Among the 20 sporadic cases, the c.686Gâ&gt;âA transition in exon 5 leading to p.Arg229Gln [<xref ref-type="bibr" rid="CR36">36</xref>] was identified in association with two different pathogenic missense mutations (TableÂ <xref rid="Tab1" ref-type="table">1</xref>). Patient P6 was compound heterozygous [p.Arg229Gln];[p.Ala284Val], as indicated by the c.851Câ&gt;âT nucleotide transition [<xref ref-type="bibr" rid="CR9">9</xref>] observed from <italic>NPHS2</italic> sequencing. Compound heterozygosis for the two mutations was demonstrated by the analysis of patient P6âs father carrying p.Ala284Val and mother carrying p.Arg229Gln (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>). Patient P67 was compound heterozygous [p.Arg229Gln];[p.Glu310Lys] which resulted from c.928Gâ&gt;âA transition in exon 8 [<xref ref-type="bibr" rid="CR37">37</xref>]. Individual mutations were also inherited from each parent, indicating an autosomal recessive inheritance for SRNS in both cases (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>). The p.Arg229Gln variant is the most frequently reported non-synonymous <italic>NPHS2</italic> variant in Caucasians; there are reports on its allele frequency showing that it is more frequent among European descendants than African descendants in the United States [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Tsukaguchi et al. demonstrated that trans-association of p.Arg229Gln with pathogenic mutations may result in a less severe phenotype such as late-onset SRNS. The most commonly associated mutation is p.Ala284Val, and notably this combination is predominant among South American populations from Chile and Argentina with adult-onset SRNS [<xref ref-type="bibr" rid="CR37">37</xref>]. Recently, Tory et al., observed that p.Arg229Gln podocin presented a subcellular mislocalization only when co-expressed with podocins carrying amino acid substitutions encoded on exons 7â8, but not with substitutions encoded on exons 1â6 [<xref ref-type="bibr" rid="CR38">38</xref>]. The authors suggested that disease-associated 3â² mutations exert a dominant-negative effect on p.Arg229Gln podocin, on the basis of a structural model of dimerization; heterodimers of p.Ala284Val podocin with p.Arg229Gln podocin showed an altered three-dimensional structural arrangement, and the authors therefore proposed this different structure contributed to the retention of p.Arg229Gln podocin within cytoplasmic compartments. However, when pathogenic mutations were associated with wild-type podocin, they behaved as recessive alleles. In summary, Tory et al. [<xref ref-type="bibr" rid="CR39">39</xref>] described a phenomenon in an autosomal recessive disorder, in which the pathogenicity of one allele depended on that of the other allele, and they proposed a pattern of mutation-dependent recessive inheritance in <italic>NPHS2</italic>-associated SRNS that is beyond Mendelâs laws. Based on these criteria, the pathogenic association [p.Arg229Gln]; [mutEx7â8] was identified in both patients P6 and P67. Patient P6 was diagnosed with SRNS when proteinuria occurred at the age of 12Â years, thus characterizing a late-onset form of the disease. Renal biopsy revealed FSGS, and the patient progressed to CKD in 3Â years when she had a kidney transplant; after approximately 1Â year post-transplant, her renal function has now returned to normal. In contrast, patient P67 developed proteinuria at 2Â years and 2Â months of age, and renal biopsy demonstrated diffuse mesangial proliferation (TableÂ <xref rid="Tab1" ref-type="table">1</xref>). The same [p.Arg229Gln];[p.Glu310Lys] association was identified by Machuca et al. [<xref ref-type="bibr" rid="CR37">37</xref>] in three patients, but all three presented with FSGS. <italic>In silico</italic> evaluation using SpliceAid2 and HSF splicing prediction tools for c.686Gâ&gt;âA (p.Arg229Gln), c.851Câ&gt;âT (p.Ala284Val) and c.928Gâ&gt;âA (p.Glu310Lys) gave the following results: SpliceAid2 prediction indicated that c.686A did not show significant modifications in splicing motifs; c.851Â T did not modify protein-binding recognition motifs; however, c.928A variant disrupted a hnRNP A1 protein-binding motif in the mutated sequence (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>). HSF prediction indicated that c.686A did not show modification in sequence motifs (data not shown); c.851Â T created an exonic ESS site; for c.928A substitution, there was an ESE site broken after HSF prediction (TableÂ <xref rid="Tab2" ref-type="table">2</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic structure of <italic>NPHS2</italic>/podocin showing the position of alterations and patientâs heredograms. <bold>a</bold> Eight exons of <italic>NPHS2</italic> gene and podocin illustration showing electropherograms of the three 5â UTR variants, four missense mutations and the frameshift mutation in the corresponding exons/domains identified in five SRNS patients. TMâ=âtransmembrane domain; PHBâ=âprohibitin domain. <bold>b</bold> Sporadic cases P6, P67 (<italic>first two boxes on the left</italic>) and family cases P103, P154 and P72 pedigrees. Black squares and circles represent patients with kidney disease. Arrow indicates the index case. Mutations are annotated below the individuals that had their <italic>NPHS2</italic> or <italic>NPHS1</italic> genes screened. P103 (II1) and her sister (II2) presented [p.Lys239Argfs*13 (;) p.Val260Glu] association. P154 (II4) and her two brothers (II5 and II6) presented the [p.Arg229Gln (;) p.Ala284Val] association</p></caption><graphic xlink:href="12881_2015_231_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Splice Aid2 and Alibaba2 gene regulation <italic>in silico</italic> predictions. <bold>a</bold> Splice Aid2 graphic outcomes from c.928Gâ&gt;âA (p.Glu310Lys) and c.779Â Tâ&gt;âA, (p.Val260Glu) substituions. Top: For c.928Gâ&gt;âA the ESS recognition site for hnRNP A1 is broken after Gâ&gt;âA substituion. Below: after c.779Â Tâ&gt;âA substitution (<italic>right</italic>) the histogram result shows that, besides the two hnRNPs (H1 and H2) proteins that putatively binds the normal ESS recognition site, a new motif is created, with the potential of being recognized by the hnRNP A1 and by other four SR proteins. Arrows on the left of histograms indicate proteins that bind ESEs and ESSs, respectively. The bars have variable width and height respectively related to the number of nucleotides of the binding site and to its score (binding affinity). Next to each bar there is the label showing the name of the protein predicted to bind to the recognition motif. Below the histogram there are two lines: one with red bars, representing the recognition motifs and with a bracket representing a putative splicing site; the other line represents the DNA sequence analyzed. A green circle highlights the nucleotide substitution. <bold>b</bold> Alibaba2 gene regulation prediction analysis showing above: wild c.-164C and mutant c.-164Â T sequences (<italic>highlighted</italic>). Wild sequence was recognized by putative transcription factors ETF-1 and GLI3 and, after substitution, these sites were abolished and a new recognition site for putative WT1 transcription factor was created. Below: no change after c.-196Câ&gt;âG substitution</p></caption><graphic xlink:href="12881_2015_231_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Exonic mutations <italic>in silico</italic> prediction</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="8">Enhancer motifs analysis through ESE finder matrices for SRp40, SC35, SF2/ASF and SRp55 proteins</th></tr></thead><tbody><tr><td rowspan="2">Sequence Variant</td><td rowspan="2">Sequence position<sup>a</sup>
</td><td rowspan="2">Linked SR<sup>b</sup> protein</td><td>Reference motif</td><td rowspan="2">Linked SR<sup>b</sup> protein</td><td colspan="2">Mutant motif</td><td rowspan="2">Variation</td></tr><tr><td>(value 0â100)<sup>c</sup>
</td><td colspan="2">(value 0â100)<sup>c</sup>
</td></tr><tr><td>c.779Â Tâ&gt;âA</td><td>776</td><td>-</td><td>-</td><td>SF2/ASF</td><td colspan="2">AAGAGGA (80.37)</td><td>New ESS site</td></tr><tr><td>c.851Câ&gt;âT</td><td>845</td><td>-</td><td>-</td><td>SF2/ASF</td><td colspan="2">CTGAAGT (75.38)</td><td>New ESS site</td></tr><tr><td>c.928Gâ&gt;âA</td><td>923</td><td>SF2/ASF</td><td>CAGCTGA (78.10)</td><td>-</td><td colspan="2">-</td><td>Site broken</td></tr><tr><td colspan="8">Potencial splice sites prediction through HSF matrices</td></tr><tr><td>Sequence Variant</td><td>Sequence position</td><td>Splice site type</td><td>Motif</td><td>New splice site</td><td>Wild type<sup>d</sup>
</td><td>Mutant<sup>d</sup>
</td><td>Variaton</td></tr><tr><td>c.779Â Tâ&gt;âA</td><td>769</td><td>Acceptor</td><td>GGAATCAAAGTGGA</td><td>ggaatcaaagagGA</td><td>38.61</td><td>67.56</td><td>New site +74.98</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Position in cDNA from ATG codon; <sup>b</sup>SRâ=âserine/arginine rich proteins; <sup>c</sup>â=âConsensus values go from 0 to 100 and the threshold is defined differently for each algorithm. Threshold for SF2/ASF from ESE finder matrices is 72.98. Every signal with a score above the defined threshold is considered to be a potential ESE/ESS. <sup>d</sup>For HSF matrices consensus values go from 0 to 100 and threshold is 65. Every signal with a score above the threshold is considered to be a splice site (donor or acceptor). When a mutation occurs if the WT score is under the threshold and the score variation is above +10Â % for HSF it is considered that the mutation creates a new splice site</p></table-wrap-foot></table-wrap></p>
        <p>Considering compound heterozygosis for the two mutations, the percentage of patients with sporadic SRNS was 10Â % (2/20). This result is in accordance with data published by others that indicated frequencies for patients bearing two heterozygous mutations varying from 6 to 17Â % among sporadic SRNS cases [<xref ref-type="bibr" rid="CR9">9</xref>â<xref ref-type="bibr" rid="CR11">11</xref>].</p>
        <p>Moreover, among the sporadic cases, there were also three cases in which we identified only one heterozygous alteration, the promoter variants c.-164Câ&gt;âT, c.-196Câ&gt;âG and c.-537_-531delCTTTTTT in patients P111, P68 and P85, respectively. Di Duca et al. [<xref ref-type="bibr" rid="CR39">39</xref>], who studied regulatory elements in the <italic>NPHS2</italic> promoter, described c.-537_-531delCTTTTTT (rs146791300, MAFâ=â0.069; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov/</ext-link>) variant as a âfunctional polymorphismâ that downregulated the gene expression of podocin by 85Â % when transfected in podocytes. As there are no records of c.-164Câ&gt;âT and c.-196Câ&gt;âG variants in the database (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org">http://www.ensembl.org</ext-link>), we screened the 700Â bp of the 5â² UTR in 278 control subjects. We identified the c.-196G in heterozygosis in two controls (2/278, &lt;1Â %), but neither c.-537_-531delCTTTTTT nor c.-164Â T were found, suggesting a possible role as disease-causing mutations. Alibaba2 gene regulation prediction algorithm showed that the Câ&gt;âG transversion in position c.-196 did not disrupt the SP1 transcription binding site located in this region (data not shown). However, this was not the case for Câ&gt;âT transition in â164 position that created a new WT1 transcription factor binding site (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>). It is well known that WT1 plays a key role during kidney and genital development [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. However, after birth, WT1 expression persists in the glomerular visceral epithelial cells where the protein probably contributes to the functional maintenance of differentiated podocytes [<xref ref-type="bibr" rid="CR40">40</xref>]. In fact, it was previously demonstrated that WT1 binds and activates a glomerular-specific <italic>NPHS1</italic> enhancer <italic>in vitro</italic> [<xref ref-type="bibr" rid="CR41">41</xref>]. Although there are no reports of WT1 acting as a trans-regulator element of the <italic>NPHS2</italic> promoter, we cannot discard a possible role for WT1 in this process, since mechanisms by which transcription factors regulate the expression of their target genes in podocytes are not yet fully understood. Recently, He et al. [<xref ref-type="bibr" rid="CR42">42</xref>] identified a putative enhancer at 743Â bp in the human <italic>NPHS2</italic> promoter that is combinatorially regulated by Lmx1b and FoxC transcription factors in podocytes. Therefore, with respect to c.-164Câ&gt;âT identified in our study, further expression and electrophoretic mobility shift assays are essential to better understand its role in podocin production. What is already known is that, in proteinuric renal disease, podocin expression is a dynamic process in which dramatic decreases or abnormal distributions of podocin expression in glomeruli of children with NS have already been demonstrated [<xref ref-type="bibr" rid="CR43">43</xref>].</p>
      </sec>
      <sec id="Sec8">
        <title>Familial cases</title>
        <p>When considering only familial cases, two out of seven unrelated cases presented two heterozygous alterations. The new frameshift p.Lys239Argfs*13 was identified in association with the already described p.Val260Glu missense in patient P103 and her sister (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>). We considered compound heterozygosis as the most probable genotype characterizing an autosomal recessive inheritance in this family, although we could not analyze their parentâs <italic>NPHS2</italic> gene. The frameshift p.Lys239Argfs*13 results from the c.714delG deletion in exon 5, and putatively produces amino acid changes from residues 239 to 251 and creates a premature stop codon at residue 252. Therefore, this mutation might affect podocin interaction with nephrin via the PHB domain, since podocin PHB domain comprises amino acids 127 to 284 [<xref ref-type="bibr" rid="CR44">44</xref>]. The missense p.Val260Glu is the result of c.779Â Tâ&gt;âA transversion in exon 6 [<xref ref-type="bibr" rid="CR11">11</xref>]. The protein resulting from this substitution is retained in the endoplasmic reticulum and loses its ability to recruit nephrin in lipid rafts [<xref ref-type="bibr" rid="CR45">45</xref>]. After <italic>in silico</italic> evaluation of c.779Â Tâ&gt;âA (p.Val260Glu) by HSF and SpliceAid2 splicing prediction tools, this substitution was classified with the potential of interfering with splicing in different ways: by activating a new exonic cryptic acceptor splice site, as predicted by HSF matrices; and by creating an ESS site, as predicted by exonic regulatory sequences (ESRs) algorithm [<xref ref-type="bibr" rid="CR46">46</xref>] as well as HSF matrices (TableÂ <xref rid="Tab2" ref-type="table">2</xref>). SpliceAid2 prediction indicated that, after Tâ&gt;âA substitution, new ESE and ESS putative binding motifs were created that might be recognized by different serine and arginine-rich (SR) proteins and heterogeneous nuclear ribonucleoproteins (hnRNP), respectively (Fig.Â <xref rid="Fig2" ref-type="fig">2</xref>). In patient P154, we also identified the [p.Arg229Gln (;) p.Ala284Val] association, as described for patient P6. Patient P154 is a 13-year-old boy with FSGS. He has five siblings, and we analyzed the <italic>NPHS2</italic> gene in two of the siblings, a sister and a brother with FSGS who also presented the [p.Arg229Gln (;) p.Ala284Val] association. Analysis of the mother revealed p.Arg229Gln; however, a DNA sample from the father was not available for analysis. Our findings also included an SRNS patient with only one heterozygous alteration in the <italic>NPHS2</italic> gene, which diverged from the concept that SRNS is an autosomal recessive disease. The p.Arg229Gln substitution was identified in patient P72 whose father also showed the disease-associated polymorphism. Patient P72 had the disease onset at 16Â years of age when he was diagnosed with FSGS upon renal biopsy. He progressed to CKD and had kidney transplant at the age of 18Â years. His father was diagnosed with FSGS and had kidney transplant about 30Â years ago, with no FSGS recurrence thereafter. The family also reported that the patientâs brother died of renal failure. Therefore, this family history suggests a possible genetic origin for the disease. Since <italic>NPHS2</italic> mutations are expected to act in a recessive mode in SRNS patients, our hypothesis is that mutations in other genes might be contributing to the disease in this family. <italic>NPHS1</italic> analysis revealed the c.1223Gâ&gt;âA substitution in exon 10, leading to the p.Arg408Gln variant [<xref ref-type="bibr" rid="CR14">14</xref>] (Fig.Â <xref rid="Fig1" ref-type="fig">1</xref>). There is some evidence, however, that this non-synonymous substitution is probably neutral, since it has been described as a polymorphism frequently found in homozygosis and heterozygosis in control individuals [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. In order to verify its frequency among Brazilians, we analyzed 100 controls and found 2Â % were heterozygous for this variant (data not shown). In addition, patient P72âs father did not show this <italic>NPHS1</italic> variant, which led to the conclusion that there might be a mutation in one of the many other genes implicated in NS that were not screened in the present work. Besides these three cases with mutations, the other four cases with a family history of SRNS did not show any mutations in the <italic>NPHS2</italic> gene. Therefore, the percentage of familial cases carrying two <italic>NPHS2</italic> mutations in our study was 28.57Â % (2/7), whereas other groups reported percentages of around 40Â % [<xref ref-type="bibr" rid="CR9">9</xref>â<xref ref-type="bibr" rid="CR11">11</xref>]. It is likely the small study sample size here could explain this difference in our frequency result.</p>
        <p>Furthermore, we also found that, among four patients bearing two heterozygous mutations, two (2/4, 50Â %) presented the [p.Arg229Gln];[p.Ala284Val] association already described as predominant in South American populations [<xref ref-type="bibr" rid="CR37">37</xref>]; apparently, this is also a common association in South Eastern Brazil. Patient P6âs grandparents are from Brazil, and the patient herself does not have a âhispanicâ background. She was the only patient who had available information about her grandparentsâ origin. The data reported here also demonstrated a considerable incidence of single heterozygous <italic>NPHS2</italic> alterations, but we cannot correlate them with a favorable outcome, since two patients (P85 and P72) progressed to CKD Class V (TableÂ <xref rid="Tab1" ref-type="table">1</xref>). Of note, one of these two patients presented a promoter variation, and, in fact, we identified three promoter variations that might downregulate podocin in the GFB of these patients. Therefore, further functional studies are necessary, in order to evaluate if these promoter variants alter the regulatory mechanisms and influence the maintenance of the barrierâs functional integrity.</p>
      </sec>
    </sec>
    <sec id="Sec9" sec-type="conclusion">
      <title>Conclusions</title>
      <p>Our study reports the identification of <italic>NPHS2</italic> mutations in only 14.8Â % of both sporadic and familial SRNS cases in the Brazilian patients analyzed, after screening for mutations in the <italic>NPHS2</italic>, <italic>NPHS1</italic> and <italic>WT1</italic> genes. The study did not reveal mutations in <italic>NPHS1</italic> and <italic>WT1</italic>. Therefore, target-oriented next generation sequencing analysis of glomerulopathy-related panel of genes is recommended to search for mutations in other genes related to SRNS.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec10">
          <title>Additional file</title>
          <p>
            <media position="anchor" xlink:href="12881_2015_231_MOESM1_ESM.doc" id="MOESM1">
              <label>Additional file 1:</label>
              <caption>
                <p>
<bold>Supplemental Information.</bold>
<bold>Table S1.</bold>
<italic>NPHS2</italic> specific primers. <bold>Table S2.</bold>
<italic>WT1</italic> exons 8 and 9 especific primers. <bold>Table S3.</bold>
<italic>NPHS1</italic> specific primers. Methods (PCR reactions and sequencing). <bold>Table S4.</bold>
<italic>NPHS2</italic> and <italic>NPHS1</italic> missenses <italic>in silico</italic> predictions. (DOC 84Â kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p>Vera MS Belangero and Gil Guerra-Junior contributed equally to this work.</p>
      </fn>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The author(s) declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authorsâ contributions</bold>
        </p>
        <p>MSG carried out the molecular genetic studies of <italic>NPHS2</italic>, <italic>NPHS1</italic> and <italic>WT1</italic> genes, sequences alignments, <italic>in silico</italic> predictions and drafted the manuscript. ACGBL was responsible for the clinical evaluation of the patients and contributed with writing clinical description of cases for the manuscript draft. CSCP participated in genomic DNA isolation from blood samples. MLS participated on molecular genetic studies of <italic>NPHS2</italic>, <italic>NPHS1</italic> and <italic>WT1</italic> genes. SRS participated on molecular genetic studies of <italic>NPHS1</italic> gene. TBH participated on molecular genetic studies of <italic>NPHS2</italic>, <italic>NPHS1</italic> and <italic>WT1</italic> genes. ATM-G participated in the design of the study. VMSB participated in the design of the study and was responsible for the clinical evaluation of the patients and contributed with writing of clinical description of cases for the manuscript draft. GG-J participated in the design of the study and helped to draft the manuscript. MP-de-M conceived the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
      <fn>
        <p>
          <bold>Authorsâ information</bold>
        </p>
        <p>Not applicable.</p>
      </fn>
      <fn>
        <p>
          <bold>Availability of data and materials</bold>
        </p>
        <p>Not applicable.</p>
      </fn>
    </fn-group>
    <ack>
      <p>We are grateful to the bioestatistic Rodrigo Secolin from âLaboratÃ³rio de Biologia Molecular da Faculdade de CiÃªncias MÃ©dicas (FCM, UNICAMP)â and to the following nephrologists for having sent the blood of some patients for molecular diagnosis, always trusting in our research: Dr. Diana RÃ©gia Bezerra Feitosa, Dr. JovÃ¢nia Heringer Sobrinho and Dr. AndrÃ©ia Ribeiro from âHospital Municipal JosÃ© de Carvalho Florence SÃ£o JosÃ© dos Camposâ; Dr. Flavia Vanesca Felix LeÃ£o, Dr. Maria Aparecida de Paula CanÃ§ado, Dr. Paulo Koch Nogueira and Luciana Feltran from âSetor Nefrologia Departamento de Pediatria da Universidade Federal de SÃ£o Pauloâ; Dr. Alberto Zagury from Rio de Janeiro - RJ and Dr. Liliane Prates (patients from Piracicaba â SP).</p>
      <sec id="d30e1786">
        <title>Funding</title>
        <p>This work was supported byÂ FundaÃ§Ã£o de Amparo Ã  Pesquisa do Estado de SÃ£o Paulo (FAPESP - 2012/51109-9 to MPdeM) andÂ the Conselho Nacional de Desenvolvimento CientÃ­fico e TecnolÃ³gico (CNPq - 478444/08-7 to G.G-J and 141072/2010 to MSG).andÂ FundaÃ§Ã£o de Amparo Ã  Pesquisa do Estado de SÃ£o Paulo (FAPESP - 2012/51109-0 to MPdeM).</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gbadegesin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smoyer</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <collab>Mosby Elsevier</collab>
          </person-group>
          <article-title>Nephrotic Syndrome</article-title>
          <source>Comprehensive Pediatric Nephrology, First</source>
          <year>2008</year>
          <fpage>205</fpage>
          <lpage>18</lpage>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benoit</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Machuca</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Antignac</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations</article-title>
          <source>Pediatr Nephrol</source>
          <year>2010</year>
          <volume>25</volume>
          <fpage>1621</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1007/s00467-010-1495-0</pub-id>
          <?supplied-pmid 20333530?>
          <pub-id pub-id-type="pmid">20333530</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sadowski</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Lovric</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ashraf</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pabst</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Gee</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Kohl</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A Single-Gene Cause in 29.5Â % of Cases of Steroid-Resistant Nephrotic Syndrome</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2014</year>
          <volume>26</volume>
          <fpage>1279</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2014050489</pub-id>
          <?supplied-pmid 25349199?>
          <pub-id pub-id-type="pmid">25349199</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boute</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gribouval</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Roselli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Benessy</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fuchshuber</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome</article-title>
          <source>Nat Genet</source>
          <year>2000</year>
          <volume>24</volume>
          <fpage>349</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1038/74166</pub-id>
          <?supplied-pmid 10742096?>
          <pub-id pub-id-type="pmid">10742096</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tryggvason</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm</article-title>
          <source>J Am Soc Nephrol</source>
          <year>1999</year>
          <volume>10</volume>
          <fpage>2440</fpage>
          <lpage>5</lpage>
          <?supplied-pmid 10541305?>
          <pub-id pub-id-type="pmid">10541305</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huber</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Simons</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hartleben</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sernetz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schmidts</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gundlach</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains</article-title>
          <source>Hum Mol Genet</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>3397</fpage>
          <lpage>405</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddg360</pub-id>
          <?supplied-pmid 14570703?>
          <pub-id pub-id-type="pmid">14570703</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morrow</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Parton</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Flotillins and the PHB domain protein family: rafts, worms and anaesthetics</article-title>
          <source>Traffic</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>725</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0854.2005.00318.x</pub-id>
          <?supplied-pmid 16101677?>
          <pub-id pub-id-type="pmid">16101677</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fuchshuber</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jean</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gribouval</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Gubler</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Broyer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Beckmann</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis</article-title>
          <source>Hum Mol Genet</source>
          <year>1995</year>
          <volume>4</volume>
          <fpage>2155</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/4.11.2155</pub-id>
          <?supplied-pmid 8589695?>
          <pub-id pub-id-type="pmid">8589695</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karle</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Uetz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ronner</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Glaeser</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hildebrandt</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fuchshuber</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>388</fpage>
          <lpage>93</lpage>
          <?supplied-pmid 11805166?>
          <pub-id pub-id-type="pmid">11805166</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruf</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Lichtenberger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Karle</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Anacleto</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Schultheiss</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>722</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1097/01.ASN.0000113552.59155.72</pub-id>
          <?supplied-pmid 14978175?>
          <pub-id pub-id-type="pmid">14978175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gribouval</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Esquivel</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>MoriniÃ¨re</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>TÃªte</surname>
              <given-names>M-J</given-names>
            </name>
            <name>
              <surname>Legendre</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence</article-title>
          <source>Kidney Int</source>
          <year>2004</year>
          <volume>66</volume>
          <fpage>571</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00776.x</pub-id>
          <?supplied-pmid 15253708?>
          <pub-id pub-id-type="pmid">15253708</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bouchireb</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Boyer</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Gribouval</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Nevo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Huynh-Cong</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>MoriniÃ¨re</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum</article-title>
          <source>Hum Mutat</source>
          <year>2014</year>
          <volume>35</volume>
          <fpage>178</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.22485</pub-id>
          <?supplied-pmid 24227627?>
          <pub-id pub-id-type="pmid">24227627</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>KestilÃ¤</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lenkkeri</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>MÃ¤nnikkÃ¶</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lamerdin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McCready</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Putaala</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome</article-title>
          <source>Mol Cell</source>
          <year>1998</year>
          <volume>1</volume>
          <fpage>575</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1016/S1097-2765(00)80057-X</pub-id>
          <?supplied-pmid 9660941?>
          <pub-id pub-id-type="pmid">9660941</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lenkkeri</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>MÃ¤nnikkÃ¶</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McCready</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lamerdin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gribouval</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Niaudet</surname>
              <given-names>PM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations</article-title>
          <source>Am J Hum Genet</source>
          <year>1999</year>
          <volume>64</volume>
          <fpage>51</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1086/302182</pub-id>
          <?supplied-pmid 9915943?>
          <pub-id pub-id-type="pmid">9915943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schoeb</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Chernin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Heeringa</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Matejas</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Held</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vega-Warner</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS)</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2010</year>
          <volume>25</volume>
          <fpage>2970</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1093/ndt/gfq088</pub-id>
          <?supplied-pmid 20172850?>
          <pub-id pub-id-type="pmid">20172850</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Philippe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nevo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Esquivel</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Reklaityte</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gribouval</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>TÃªte</surname>
              <given-names>M-J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2008</year>
          <volume>19</volume>
          <fpage>1871</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2008010059</pub-id>
          <?supplied-pmid 18614772?>
          <pub-id pub-id-type="pmid">18614772</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koziell</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grech</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hussain</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lenkkeri</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Tryggvason</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration</article-title>
          <source>Hum Mol Genet</source>
          <year>2002</year>
          <volume>11</volume>
          <fpage>379</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/11.4.379</pub-id>
          <?supplied-pmid 11854170?>
          <pub-id pub-id-type="pmid">11854170</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Call</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Glaser</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Buckler</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Pelletier</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Haber</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilmsâ tumor locus</article-title>
          <source>Cell</source>
          <year>1990</year>
          <volume>60</volume>
          <fpage>509</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1016/0092-8674(90)90601-A</pub-id>
          <?supplied-pmid 2154335?>
          <pub-id pub-id-type="pmid">2154335</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gessler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Poustka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cavenee</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Neve</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Orkin</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Bruns</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
          <article-title>Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping</article-title>
          <source>Nature</source>
          <year>1990</year>
          <volume>343</volume>
          <fpage>774</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1038/343774a0</pub-id>
          <?supplied-pmid 2154702?>
          <pub-id pub-id-type="pmid">2154702</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Denys</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Malvaux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Van Den Berghe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tanghe</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Proesmans</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Association of an anatomo-pathological syndrome of male pseudohermaphroditism, Wilmsâ tumor, parenchymatous nephropathy and XX/XY mosaicism</article-title>
          <source>Arch franÃ§aises pÃ©diatrie</source>
          <year>1967</year>
          <volume>24</volume>
          <fpage>729</fpage>
          <lpage>39</lpage>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drash</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sherman</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hartmann</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Blizzard</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>A syndrome of pseudohermaphroditism, Wilmsâ tumor, hypertension, and degenerative renal disease</article-title>
          <source>J Pediatr</source>
          <year>1970</year>
          <volume>76</volume>
          <fpage>585</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-3476(70)80409-7</pub-id>
          <?supplied-pmid 4316066?>
          <pub-id pub-id-type="pmid">4316066</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frasier</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Bashore</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Mosier</surname>
              <given-names>HD</given-names>
            </name>
          </person-group>
          <article-title>Gonadoblastoma associated with pure gonadal dysgenesis in monozygous twins</article-title>
          <source>J Pediatr</source>
          <year>1964</year>
          <volume>64</volume>
          <fpage>740</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-3476(64)80622-3</pub-id>
          <?supplied-pmid 14149008?>
          <pub-id pub-id-type="pmid">14149008</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lipska</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Ranchin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Iatropoulos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gellermann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Melk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ozaltin</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genotype-phenotype associations in WT1 glomerulopathy</article-title>
          <source>Kidney Int</source>
          <year>2014</year>
          <volume>85</volume>
          <fpage>1169</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2013.519</pub-id>
          <?supplied-pmid 24402088?>
          <pub-id pub-id-type="pmid">24402088</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>ISKDC</collab>
          </person-group>
          <article-title>The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children</article-title>
          <source>J Pediatr</source>
          <year>1981</year>
          <volume>98</volume>
          <fpage>561</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-3476(81)80760-3</pub-id>
          <pub-id pub-id-type="pmid">7205481</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hogg</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Furth</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lemley</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Portman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Coresh</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>National Kidney Foundationâs Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification</article-title>
          <source>Pediatrics</source>
          <year>2003</year>
          <volume>111</volume>
          <fpage>1416</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1542/peds.111.6.1416</pub-id>
          <?supplied-pmid 12777562?>
          <pub-id pub-id-type="pmid">12777562</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sambrook</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fritsh</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Maniatis</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <source>Molecular cloning: A laboratory manual</source>
          <year>1989</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Henikoff</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Predicting deleterious amino acid substitutions</article-title>
          <source>Genome Res</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>863</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.176601</pub-id>
          <?supplied-pmid 11337480?>
          <pub-id pub-id-type="pmid">11337480</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramensky</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sunyaev</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Human non-synonymous SNPs: server and survey</article-title>
          <source>Nucleic Acids Res</source>
          <year>2002</year>
          <volume>30</volume>
          <fpage>3894</fpage>
          <lpage>900</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkf493</pub-id>
          <?supplied-pmid 12202775?>
          <pub-id pub-id-type="pmid">12202775</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tavtigian</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Deffenbaugh</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Judkins</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Scholl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Samollow</surname>
              <given-names>PB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral</article-title>
          <source>J Med Genet</source>
          <year>2006</year>
          <volume>43</volume>
          <fpage>295</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="doi">10.1136/jmg.2005.033878</pub-id>
          <?supplied-pmid 16014699?>
          <pub-id pub-id-type="pmid">16014699</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</article-title>
          <source>Nucleic Acids Res</source>
          <year>1994</year>
          <volume>22</volume>
          <fpage>4673</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/22.22.4673</pub-id>
          <?supplied-pmid 7984417?>
          <pub-id pub-id-type="pmid">7984417</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desmet</surname>
              <given-names>F-O</given-names>
            </name>
            <name>
              <surname>Hamroun</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lalande</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Collod-BÃ©roud</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Claustres</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>BÃ©roud</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Human Splicing Finder: an online bioinformatics tool to predict splicing signals</article-title>
          <source>Nucleic Acids Res</source>
          <year>2009</year>
          <volume>37</volume>
          <pub-id pub-id-type="doi">10.1093/nar/gkp215</pub-id>
          <?supplied-pmid 19339519?>
          <pub-id pub-id-type="pmid">19339519</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piva</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Giulietti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nocchi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Principato</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>SpliceAid: a database of experimental RNA target motifs bound by splicing proteins in humans</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>1211</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp124</pub-id>
          <?supplied-pmid 19261717?>
          <pub-id pub-id-type="pmid">19261717</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grabe</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>AliBaba2: context specific identification of transcription factor binding sites</article-title>
          <source>In Silico Biol</source>
          <year>2002</year>
          <volume>2</volume>
          <fpage>S1</fpage>
          <lpage>15</lpage>
          <?supplied-pmid 11808873?>
          <pub-id pub-id-type="pmid">11808873</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanna-Cherchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Burgess</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Nees</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Caridi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Weng</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Dagnino</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome</article-title>
          <source>Kidney Int</source>
          <year>2011</year>
          <volume>80</volume>
          <fpage>389</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2011.148</pub-id>
          <?supplied-pmid 21697813?>
          <pub-id pub-id-type="pmid">21697813</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gee</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ashraf</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kohl</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sadowski</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Vega-Warner</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>KANK deficiency leads to podocyte dysfunction and nephrotic syndrome</article-title>
          <source>J Clin Invest</source>
          <year>2015</year>
          <volume>125</volume>
          <fpage>2375</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI79504</pub-id>
          <?supplied-pmid 25961457?>
          <pub-id pub-id-type="pmid">25961457</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsukaguchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sudhakar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schwimmer</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele</article-title>
          <source>J Clin Invest</source>
          <year>2002</year>
          <volume>110</volume>
          <fpage>1659</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI0216242</pub-id>
          <?supplied-pmid 12464671?>
          <pub-id pub-id-type="pmid">12464671</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Machuca</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hummel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nevo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dantal</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Al-Sabban</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant</article-title>
          <source>Kidney Int</source>
          <year>2009</year>
          <volume>75</volume>
          <fpage>727</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2008.650</pub-id>
          <?supplied-pmid 19145239?>
          <pub-id pub-id-type="pmid">19145239</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tory</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>MenyhÃ¡rd</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Nevo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gribouval</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kerti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>StrÃ¡ner</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation-dependent recessive inheritance in NPHS2-associated steroid-resistant nephrotic syndrome. Beyond Mendelâs laws</article-title>
          <source>Eur J Hum Genet</source>
          <year>2013</year>
          <volume>21, Supple</volume>
          <fpage>50</fpage>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Duca</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oleggini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sanna-Cherchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pasquali</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Di Donato</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Parodi</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases</article-title>
          <source>Kidney Int</source>
          <year>2006</year>
          <volume>70</volume>
          <fpage>1332</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.ki.5001767</pub-id>
          <?supplied-pmid 16900088?>
          <pub-id pub-id-type="pmid">16900088</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hammes</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Lutsch</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Leheste</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Landrock</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ziegler</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Two splice variants of the Wilmsâ tumor 1 gene have distinct functions during sex determination and nephron formation</article-title>
          <source>Cell</source>
          <year>2001</year>
          <volume>106</volume>
          <fpage>319</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00453-6</pub-id>
          <?supplied-pmid 11509181?>
          <pub-id pub-id-type="pmid">11509181</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Licht</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Quaggin</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>WT1 activates a glomerular-specific enhancer identified from the human nephrin gene</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>2851</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1097/01.ASN.0000143474.91362.C4</pub-id>
          <?supplied-pmid 15504938?>
          <pub-id pub-id-type="pmid">15504938</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <mixed-citation publication-type="other">He B, Ebarasi L, Zhao Z, Guo J, Ojala JRM, Hultenby K, et al.: Lmx1b and FoxC Combinatorially Regulate Podocin Expression in Podocytes. J Am Soc Nephrol 2014; DOI: 10.1681/ASN.2012080823</mixed-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Expression of nephrin, podocin, alpha-actinin, and WT1 in children with nephrotic syndrome</article-title>
          <source>Pediatr Nephrol</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>1122</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1007/s00467-003-1240-z</pub-id>
          <?supplied-pmid 12961083?>
          <pub-id pub-id-type="pmid">12961083</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Relle</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cash</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Brochhausen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Strand</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Menke</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Galle</surname>
              <given-names>PR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New perspectives on the renal slit diaphragm protein podocin</article-title>
          <source>Mod Pathol</source>
          <year>2011</year>
          <volume>24</volume>
          <fpage>1101</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.2011.58</pub-id>
          <?supplied-pmid 21499232?>
          <pub-id pub-id-type="pmid">21499232</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roselli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Moutkine</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gribouval</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Benmerah</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Antignac</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations</article-title>
          <source>Traffic</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>37</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1600-0854.2003.00148.x</pub-id>
          <?supplied-pmid 14675423?>
          <pub-id pub-id-type="pmid">14675423</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goren</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ram</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Amit</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Keren</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lev-Maor</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vig</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparative analysis identifies exonic splicing regulatory sequences--The complex definition of enhancers and silencers</article-title>
          <source>Mol Cell</source>
          <year>2006</year>
          <volume>22</volume>
          <fpage>769</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2006.05.008</pub-id>
          <?supplied-pmid 16793546?>
          <pub-id pub-id-type="pmid">16793546</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lahdenkari</surname>
              <given-names>A-T</given-names>
            </name>
            <name>
              <surname>KestilÃ¤</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Holmberg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Koskimies</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jalanko</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS)</article-title>
          <source>Kidney Int</source>
          <year>2004</year>
          <volume>65</volume>
          <fpage>1856</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00583.x</pub-id>
          <?supplied-pmid 15086927?>
          <pub-id pub-id-type="pmid">15086927</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>